Phase II study of paclitaxel combined with capecitabine as second-line treatment for advanced gastric carcinoma after failure of cisplatin-based regimens

Patterns of Cancer Incidence, Mortality, and Prevalence Across Five Continents: Defining Priorities to Reduce Cancer Disparities in Different Geographic Regions of the World

Farin Kamangar, Graça M. Dores, William F. Anderson · Journal of Clinical Oncology · 2006 · 3.5K citations

Medicine, Oncology, Preventive Medicine +17

Phase III Study of Docetaxel and Cisplatin Plus Fluorouracil Compared With Cisplatin and Fluorouracil As First-Line Therapy for Advanced Gastric Cancer: A Report of the V325 Study Group

Eric Van Cutsem, Vladimir Moiseyenko, Sergei Tjulandin et al. · Journal of Clinical Oncology · 2006 · 1.9K citations · Full text

Medicine, Oncology, Pharmacology +11

One-Sample Multiple Testing Procedure for Phase II Clinical Trials

Thomas R. Fleming · Biometrics · 1982 · 997 citations

Medicine, Oncology, Clinical Trial Regulation +13

Randomized trial comparing epirubicin, cisplatin, and fluorouracil versus fluorouracil, doxorubicin, and methotrexate in advanced esophagogastric cancer.

Andrew Webb, David Cunningham, J.H. Scarffe et al. · Journal of Clinical Oncology · 1997 · 873 citations

Medicine, Oncology, Pharmacology +15

Randomized comparison between chemotherapy plus best supportive care with best supportive care in advanced gastric cancer

Bengt Glimelius, Karin M. Ekström, Katarina Hoffman et al. · Annals of Oncology · 1997 · 860 citations

Medicine, Oncology, Chemotherapy +11